comparemela.com

Latest Breaking News On - Epworth sleepiness - Page 1 : comparemela.com

Patients With Insomnia or Suspected Co-Morbid Sleep Apnea Respond Positively to Cognitive Behavioral Therapy Program

A secondary analysis investigating the efficacy of a digital, interactive cognitive behavioral therapy program for insomnia (CBTi) demonstrated the positive impacts of the program for patients with insomnia or a high risk of co-morbid insomnia and sleep apnea (COMISA).

Cognitive behavioral therapyWho cant sleepBedtime windowInsomnia severity indexEpworth sleepinessSleep disordersSleep apnea

Oral Appliance for Sleep Apnea Noninferior to CPAP for Reducing Arterial BP

For patients with hypertension, oral device may be an option for those who cannot tolerate CPAP

United statesFort pierceColl cardiolEd susmanEdward fryPpamerican college of cardiologyJournal of the american college cardiologyAmerican academy of sleep medicineAmerican college of cardiologyVincent heart centerAmerican collegeEpworth sleepinessAmerican academySleep medicineApnea hypopnea index

Zevra Highlights Plans to Advance IH, Narcolepsy Drug Candidate

Zevra reported progress in 2023, including results from a phase 2 study for idiopathic hypersomnia and plans to expand into narcolepsy.

Neilf mcfarlaneDrug administrationZevra therapeutics incInvestigational new drugTherapeutics incEpworth sleepinessIdiopathic hypersomnia severity scaleSleep inertia visual analog scaleBrain fog

KP1077 Is Safe, Tolerable for Improving Idiopathic Hypersomnia Symptoms

A phase 2 trial found KP1077 provides clinically meaningful benefits for idiopathic hypersomnia.

United statesChristopher drakeHenry ford health christopher drakeAmerican academy of sleep medicineDrug administrationUs drug enforcement agencyHenry ford healthZevra therapeuticsAmerican academyOrphan drug designationEnforcement agencyEpworth sleepiness scaleIdiopathic hypersomnia severity scaleSleep inertia visual analog scaleEpworth sleepinessBrain fog severity scale

Zevra Therapeutics Reports Fourth Quarter and Full Year

Zevra Therapeutics Reports Fourth Quarter and Full Year
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesNeilf mcfarlaneNichol ochsnerAdannag alexanderDrug administrationExchange commissionAccess programCompany expanded access programEuropean medicines agencyCompany annual report on formUs drug enforcement agencyUniversity of washingtonZevra therapeutics incCompany quarterly reports on formPatient servicesAudit committee

vimarsana © 2020. All Rights Reserved.